Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization;Zytogenetische veränderungen bei nierentumoren. Einsatzmö glichkeiten von chromosomen-CGH und fluoreszenz-in-situ-hybridisierung

Urologe - Ausgabe A

Volumn 45, Issue 3, 2006, Pages 316-322

  Mertz, K D ^a,b,e   Tchinda, J ^a,b   Kufer R ^d   Moller P ^d   Rubin, M A ^a,b,c   Moch, H ^e   Perner, S ^a,b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Chromosome; Comparative genomic hybridization (CGH); Cytogenetics; Fluorescence in situ hybridization (FISH); Renal cell carcinoma

Indexed keywords

CANCER DIAGNOSIS; CANCER GROWTH; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 11Q; CHROMOSOME 13; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 21; CHROMOSOME 3; CHROMOSOME 3P; CHROMOSOME 6; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CLEAR CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DISEASE CLASSIFICATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; KIDNEY TUMOR; ONCOCYTOMA; PAPILLARY CARCINOMA; REVIEW; SEX CHROMOSOME; TETRASOMY; TRISOMY; WORLD HEALTH ORGANIZATION; Y CHROMOSOME;

CARCINOMA, RENAL CELL; CHROMOSOME BANDING; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HUMANS; HYBRIDIZATION, GENETIC; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; PROGNOSIS; TRANSLOCATION, GENETIC;

EID: 33645047381     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-006-1004-z     Document Type: Review

References (28)

1. Argani P, Ladanyi M (2005) Translocation carcinomas of the kidney. Clin Lab Med 25: 363-78
2. Bauman JG, Wiegant J, Borst P, van Duijn P (1980) A new method for fluorescence microscopical localization of specific DNA sequences by in situ hybridization of fluorochromelabelled RNA. Exp Cell Res 128: 485-490
3. Bissig H, Richter J, Desper R et al. (1999) Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. Am J Pathol 155: 267-274
4. Bodmer D, Eleveld M, Kater-Baats E et al. (2002) Disruption of a novel MFS transporter gene, DI-RC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21). Hum Mol Genet 11: 641-649
5. Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG (2002) Understanding familial and non-familial renal cell cancer. Hum Mol Genet 11: 2489-2498
6. Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L (2003) Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod Pathol 16: 1053-1059
7. Corless CL, Aburatani H, Fletcher JA, Housman DE, Amin MB, Weinberg DS (1996) Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn Mol Pathol 5: 53-64
8. Fischer J, Palmedo G, von Knobloch R, Bugert P, Prayer-Galetti T, Pagano F, Kovacs G (1998) Duplication and overexpression of the mutant allele of the MET proto- oncogene in multiple hereditary papillary renal cell tumours. Oncogene 17: 733-739
9. Fuzesi L, Gunawan B, Braun S, Bergmann F, Brauers A, Effert P, Mittermayer C (1998) Cytogenetic analysis of 11 renal oncocytomas: further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly. Cancer Genet Cytogenet 107: 1-6
10. Garraway LA, Widlund HR, Rubin MA et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436: 117-122
11. Gemmill RM, West JD, Boldog F et al. (1998) The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc Natl Acad Sci USA 95: 9572-9577
12. Harrison CJ, Foroni L (2002) Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Rev Clin Exp Hematol 6: 91-113; discussion 200-112
13. Jiang F, Desper R, Papadimitriou CH et al. (2000) Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res 60: 6503-6509
14. Jiang F, Richter J, Schraml P et al. (1998) Chromosomal imbalances in papillary renal cell carcinoma: Genetic differences between histologic subtypes. Am J Pathol 153: 1467-1473
15. Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray J, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821
16. Knuutila S, Bjorkqvist AM, Autio K et al. (1998) DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 152: 1107-1123
17. Levsky JM, Singer RH (2003) Fluorescence in situ hybridization: past, present and future. J Cell Sci 116: 2833-2838
18. Moch H, Presti JC Jr, Sauter G, Buchholz N, Jordan P, Mihatsch MJ, Waldman FM (1996) Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56: 27-30
19. Presti J, Moch H, Reuter V, Huynh D, Waldman F (1996) Chromosome 1 and 14 loss in renal oncocytomas. Genes Chromos Cancer 17: 199-204
20. Receveur AO, Couturier J, Molinie V et al. (2005) Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization. Cancer Genet Cytogenet 158: 110-118
21. Reutzel D, Mende M, Naumann S, Storkel S, Brenner W, Zabel B, Decker J (2001) Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization. Cytogenet Cell Genet 93: 221-227
22. Sanjmyatav J, Rubtsov N, Starke H, Schubert J, Hindermann W, Junker K (2005) Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization. J Urol 174: 731-735
23. Schullerus D, von Knobloch R, Chudek J, Herbers J, Kovacs G (1999) Microsatellite analysis reveals deletion of a large region at chromosome 8p in conventional renal cell carcinoma. Int J Cancer 80: 22-24
24. Sidhar SK, Clark J, Gill S et al. (1996) The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 5: 1333-1338
25. Speicher M, Schoell B, Du Manoir S et al. (1994) Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 145: 356-364
26. Swiger RR, Tucker JD (1996) Fluorescence in situ hybridization: a brief review. Environ Mol Mutagen 27: 245-254
27. 26a. van Kessel AG, Wijnhoven H, Bodmer D et al. (1999) Renal cell cancer: chromosome 3 translocations as risk factors. J Natl Cancer Inst 91: 1159-1160
28. Weiss MM, Hermsen MA, Meijer GA et al. (1999) Comparative genomic hybridisation. Mol Pathol 52: 243-251